Avior Wealth Management LLC Acquires Shares of 418 Encompass Health Co. (NYSE:EHC)

Avior Wealth Management LLC bought a new stake in shares of Encompass Health Co. (NYSE:EHC) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 418 shares of the company’s stock, valued at approximately $40,000.

Other institutional investors and hedge funds have also modified their holdings of the company. UMB Bank n.a. boosted its position in Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares during the last quarter. Oakworth Capital Inc. bought a new stake in shares of Encompass Health in the 2nd quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. increased its holdings in Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after buying an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in Encompass Health in the second quarter valued at approximately $58,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.9 %

Shares of Encompass Health stock opened at $102.00 on Tuesday. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The company’s fifty day simple moving average is $97.28 and its 200-day simple moving average is $90.99. The company has a market cap of $10.28 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 1.34 and a beta of 0.88. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the business posted $0.86 EPS. The business’s quarterly revenue was up 11.9% on a year-over-year basis. As a group, sell-side analysts expect that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s payout ratio is presently 16.43%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on EHC shares. UBS Group raised their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Truist Financial restated a “buy” rating and set a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Barclays upped their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Stephens reaffirmed an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a research report on Tuesday, August 6th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Encompass Health has an average rating of “Buy” and an average price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.